Jul 2026· Frontiers in Cell and Developmental Biology· Vol 14· 0 citations· 49 references
Medicine
TL;DR
Findings define a clonally evolved epithelial subtype associated with lymphatic invasion and provide mechanistic insights into tumor cell plasticity and stromal–epithelial interactions underlying bladder cancer progression.
Abstract
Tumor progression and metastasis in bladder cancer are driven by epithelial cell heterogeneity and dynamic interactions with the tumor microenvironment. To elucidate epithelial subpopulations associated with cancer progression, we performed single-cell transcriptomic profiling of bladder cancer tissues and identified a distinct epithelial subset, termed Meta-program 6 (MP6), that was significantly enriched in samples exhibiting lymphovascular invasion or lymph node metastasis. The MP6 gene signature correlated strongly with advanced tumor stage, lymph node involvement, and lymphovascular infiltration. CNV analysis revealed extensive chromosomal alterations, particularly chromosome 19 deletion, indicating genomic instability. Cell–cell communication analysis demonstrated active crosstalk between MP6 tumor cells and cancer-associated fibroblasts, including WNT and BMP signaling pathways, indicating that stromal crosstalk may contribute to the establishment of a pro-tumorigenic microenvironment. Transcription factor network inference further identified elevated activity of regulators such as TFCP2 and ELF1, implicating them in the acquisition of aggressive phenotypes. Immunohistochemical validation supported the clinical relevance of selected MP6-associated targets. Collectively, these findings define a clonally evolved epithelial subtype associated with lymphatic invasion and provide mechanistic insights into tumor cell plasticity and stromal–epithelial interactions underlying bladder cancer progression.
GSDMD dysregulation correlates with activated EMT and lymphangiogenic signaling, potentially facilitating tumor lymphatic dissemination, and is highlighted as a promising therapeutic candidate for restraining cervical cancer metastatic progression.
Fu-Feng Gao, Hang Yu, Hui-Can Guo et al.· Journal of Inflammation Rese...· 0 citations
Single-cell transcriptomics of publicly available BLCA data identifies two transcriptionally distinct fibroblast states in adjacent tissue and supports an exploratory ligand–receptor interaction framework, warranting prospective validation with primary CAF populations and adequately powered multi-specimen cohorts.
Yan-Dong He, Wen-Long Lu, Guan-Qun Ju et al.· Frontiers in Cell and Develo...· 0 citations
Findings indicate that a pro-tumorigenic microenvironment associated with disease progression in bladder cancer exists within peri-tumoral TLS and potentially a factor underlying contrasting therapeutic associations potentially driven by live microbial versus targeted immunomodulatory therapy in NMIBC and MIBC.
These findings identify CELSR2 as a previously unknown regulator of epithelial-mesenchymal plasticity and reveal that heterogeneous CELSR2 expression shapes spatially and functionally distinct tumor cell populations, thereby contributing to intratumoral heterogeneity in TNBC.
Julia Koren, Nour-Islem Yanis Saidani, Abdessamad Elkaoutari et al.· bioRxiv· 0 citations
These findings identify a tumor-adapted MC state that orchestrates immune evasion and tissue remodeling during CRC progression, supporting the notion that MC are reprogrammed toward an immune-suppressive and pro-tumorigenic phenotype.
E. Putro, Alessia Carnevale, Caterina Marangio et al.· Cell Death & Disease· 0 citations
It is suggested that C7 fibroblasts being predominantly distributed in tumor‐adjacent normal tissues is significantly associated with cervical cancer progression, and that C7 fibroblasts in these tissues may serve as potential biomarkers and therapeutic targets for tumor microenvironment modulation.
Yi Liu, D. Yin, Lu-guang Wu et al.· Frontiers in Cell and Develo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.